Product Information
BUDESONIDE DR 3 MG CAPSULE is a generic product labeled by NorthStar Rx LLC, priced at $0.4975 per EA under NDC 16714082901. Its NADAC has been published 405 times since Jan 2, 2019.
FDA first approved this application on May 4, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714082901
Classification
Generic
Dosage Form
CAPSULE, COATED PELLETS
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206134FDA Approved
5/4/2017
TE Code
AB
On Market Since
6/25/2018
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE DR 3 MG CAPSULE has been published 405 times since Jan 2, 2019, and over the history we have for it it has declined 79.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4975 per EA |
|---|---|
| All-time high | $2.3661 (Jan 16, 2019) |
| All-time low | $0.4242 (Nov 20, 2024) |
| 52-week high | $0.5230 |
| 52-week low | $0.4975 |
| Median price | $0.7057 |
| Average price | $0.9389 |
| Largest weekly change | -35.6% (Apr 22, 2020) |
| Weeks tracked | 405 |
| Tracking since | Jan 2, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
budesonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUDESONIDE DR 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE DR 3 MG CAPSULE, manufactured by NorthStar Rx LLC, is $0.4975 per EA (NDC 16714082901), effective Sep 30, 2026.
How has the price of BUDESONIDE DR 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUDESONIDE DR 3 MG CAPSULE has declined 79.0%. It has been tracked across 405 weekly CMS publications since Jan 2, 2019.
What are the highest and lowest recorded NADAC prices for BUDESONIDE DR 3 MG CAPSULE?
Since Jan 2, 2019, the NADAC for BUDESONIDE DR 3 MG CAPSULE has ranged from a low of $0.4242 (Nov 20, 2024) to a high of $2.3661 (Jan 16, 2019), with a median of $0.7057 per EA.
Are there cheaper alternatives to BUDESONIDE DR 3 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUDESONIDE DR 3 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BUDESONIDE DR 3 MG CAPSULE?
BUDESONIDE DR 3 MG CAPSULE (NDC 16714082901) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.